Invention Grant
![Substituted triazolo[1,5-a]pyridines and triazolo[1,5-a]pyrazines as LSD1 inhibitors](/docs/US/2017-07-04/US09695167B2/abs.jpg.600x600.jpg)
- Patent Title: Substituted triazolo[1,5-a]pyridines and triazolo[1,5-a]pyrazines as LSD1 inhibitors
-
Application No.: US14795499Application Date: 2015-07-09
-
Publication No.: US09695167B2Publication Date: 2017-07-04
- Inventor: Liangxing Wu , Xiaozhao Wang , Wenqing Yao , Colin Zhang
- Applicant: Incyte Corporation
- Applicant Address: US DE Wilmington
- Assignee: Incyte Corporation
- Current Assignee: Incyte Corporation
- Current Assignee Address: US DE Wilmington
- Agency: Fish & Richardson P.C.
- Main IPC: A61K31/4745
- IPC: A61K31/4745 ; A61K31/4985 ; C07D471/04 ; C07D487/04
![Substituted triazolo[1,5-a]pyridines and triazolo[1,5-a]pyrazines as LSD1 inhibitors](/abs-image/US/2017/07/04/US09695167B2/abs.jpg.150x150.jpg)
Abstract:
The present invention is directed to [1,2,4]triazolo[1,5-a]pyridine and [1,2,4]triazolo[1,5-a]pyrazine derivatives of Formula I, or a pharmaceutically acceptable salt thereof, which are LSD1 inhibitors useful in the treatment of diseases such as cancer.
Public/Granted literature
- US20160009711A1 TRIAZOLOPYRIDINES AND TRIAZOLOPYRAZINES AS LSD1 INHIBITORS Public/Granted day:2016-01-14
Information query
IPC分类:
